Novo Nordisk

Novo Nordisk is one of the leading companies within treatment of diabetes in the world. They have the broadest assortment of diabetes products - among which is the most advanced systems for dosing of insulin.

Furthermore, they have a leading position within other areas as treatment of bleeding, growth hormone treatment and hormone preparations for treatment of climacteric discomfort.

Novo Nordisk develops, produces and markets pharmaceutical products and services, which make a big difference to patients, practitioners and society.

Edora A/S and Novo Nordisk A/S are cooperating on updating the production platform.

Lyngby Hovedgade 98 - DK-2800 Kgs. Lyngby - (+45) 70 27 00 10 - edora@edora.dk